Fig. 5 | Modern Pathology

Fig. 5

From: Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases

Fig. 5

Overall survival and disease-specific survival curves for methotrexate-associated T-cell lymphoproliferative disorder of angioimmunoblastic T-cell lymphoma type compared to angioimmunoblastic T-cell lymphoma. Patients with methotrexate-associated T-cell lymphoproliferative disorder of angioimmunoblastic T-cell lymphoma type (MTX-AITL) had superior overall survival curve and progression-free survival curve, though the differences from angioimmunoblastic T-cell lymphoma (AITL) were not significant (a, b). Overall survival and progression-free survival curves for the patients of the two groups who are 60 years or older were also compared. The survival curves showed the same trend (c, d)

Back to article page